Yongzhong Li - Shanghai Pharmaceuticals VP Director

601607 Stock   21.42  0.31  1.43%   

Director

Yongzhong Li is VP Director of Shanghai Pharmaceuticals Holding
Age 54
Address Shanghai Pharmaceutical Building, Shanghai, China, 200020
Phone86 21 6373 0908
Webhttps://www.sphchina.com

Shanghai Pharmaceuticals Management Efficiency

The company has return on total asset (ROA) of 0.0241 % which means that it generated a profit of $0.0241 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0641 %, meaning that it generated $0.0641 on every $100 dollars invested by stockholders. Shanghai Pharmaceuticals' management efficiency ratios could be used to measure how well Shanghai Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At present, Shanghai Pharmaceuticals' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 3.7 B, whereas Net Tangible Assets are forecasted to decline to about 28.6 B.

Similar Executives

Showing other executives

DIRECTOR Age

Wei YanShaanxi Meineng Clean
47
Xue LingGem Year Industrial Co
62
Fuquan LangGem Year Industrial Co
54
Jin CaiGem Year Industrial Co
44
Dongliang FuBus Online Co
42
Xue LiPengxin International Mining
53
Yuan OuGem Year Industrial Co
64
Feng XueKingclean Electric Co
56
Zu NiKingclean Electric Co
67
Ke LiGansu Yasheng Industrial
58
Ji NiuGansu Yasheng Industrial
54
Yu LinGem Year Industrial Co
66
Wenjie XieBus Online Co
43
Jian HanKingclean Electric Co
57
Lin LiShaanxi Meineng Clean
54
You JiangGansu Yasheng Industrial
54
Xue YuNingbo Ligong Online
44
Lifeng YangShaanxi Meineng Clean
54
Shanghai Pharmaceuticals Holding (601607) is traded on Shanghai Stock Exchange in China and employs 48,164 people. Shanghai Pharmaceuticals is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

Shanghai Pharmaceuticals Leadership Team

Elected by the shareholders, the Shanghai Pharmaceuticals' board of directors comprises two types of representatives: Shanghai Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shanghai. The board's role is to monitor Shanghai Pharmaceuticals' management team and ensure that shareholders' interests are well served. Shanghai Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shanghai Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
Shuai Shao, Vice President
Qiuhua Yang, Executive Chairman
Ying Ke, Director Center
Tao Zhong, Board VP
Man Cho, Pres Director
Shunjiang Yu, Chief Officer
Bo CPA, CFO and Presidentident
Ming Dong, Executive Director
Dongming Li, Vice President
Yongzhong Li, VP Director
Jinqi Yu, G Mang
Shui ACS, Joint Secretary
Pui Wong, Joint Secretary
Bo Shen, CFO, President
Linqiong Dong, Securities Representative

Shanghai Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Shanghai Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Shanghai Stock

Shanghai Pharmaceuticals financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Pharmaceuticals security.